Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITD (Q84528309)
Jump to navigation
Jump to search
scientific article published on 02 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITD |
scientific article published on 02 July 2012 |
Statements
Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITD (English)
Gaëlle Labouré
Stéphanie Dulucq
Reza Tabrizi
Estelle Guérin
Arnaud Pigneux
Xavier Lafarge
Thibaut Leguay
Krimo Bouabdallah
Marie-Sarah Dilhuydy
Cédric Duclos
Axelle Lascaux
Gérald Marit
François-Xavier Mahon
Jean-Michel Boiron
Stéphane Vigouroux